Product image of Lacosamide Strides (Lacosamide) supplied by GNH India

Lacosamide Strides

Active Ingredient:
Lacosamide
Origin:
EU

Lacosamide Strides (Lacosamide)

Lacosamide, the active ingredient in Lacosamide Strides, is an anticonvulsant presented as an oral formulation for oral use. It treats partial‑onset seizures and epilepsy in patients requiring seizure control.

GNH India supplies Lacosamide Strides as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Strides Nordic Aps

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Lacosamide is an anticonvulsant used in the management of seizure disorders, particularly focal epilepsies.

  • Partial‑onset seizures: reduces seizure frequency when used as adjunctive therapy.
  • Focal epilepsy: provides additional seizure control for patients not fully managed by other agents.
  • Epilepsy (generalized): may be employed as part of a broader treatment regimen in appropriate clinical contexts.

How It Works

  • Lacosamide enhances the slow inactivation of voltage‑gated sodium channels, stabilizing neuronal membranes and decreasing hyper‑excitability. By selectively targeting the persistent sodium current, it limits repetitive neuronal firing without affecting normal conduction, thereby contributing to seizure suppression.

Side Effects

Lacosamide may cause a range of adverse reactions, from mild to serious.

Common Side Effects

  • Dizziness: transient light‑headedness, especially after dose initiation.
  • Nausea: mild gastrointestinal upset, often resolves with continued use.
  • Headache: mild to moderate intensity, usually improves over time.
  • Fatigue: general tiredness that may lessen with dose adjustment.
  • Blurred vision: temporary visual disturbances.
  • Diplopia: double vision, typically dose‑related.

Serious or Rare Side Effects

  • Suicidal ideation: new or worsening thoughts of self‑harm.
  • Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis.
  • Cardiac arrhythmias: PR‑interval prolongation or atrioventricular block.
  • Respiratory depression: especially when combined with CNS depressants.
  • Hepatotoxicity: elevated liver enzymes or hepatic dysfunction.
  • Blood dyscrasias: rare cases of agranulocytosis or thrombocytopenia.

Precautions & Warnings

Before prescribing Lacosamide, clinicians should consider several safety factors.

  • Renal impairment: adjust dosing in patients with reduced kidney function.
  • Hepatic impairment: monitor liver enzymes and consider dose modification.
  • Cardiac conduction disorders: avoid in patients with known PR‑interval prolongation.
  • Pregnancy: safety category unknown; weigh potential benefits against risks.
  • Concomitant antiepileptics: monitor for additive CNS effects.
  • Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture.

Avoid Interactions

Lacosamide can interact with other medicines, influencing efficacy or safety.

Major Interactions (Avoid)

  • Strong CYP3A4 inducers (e.g., carbamazepine, phenytoin, phenobarbital): may markedly reduce lacosamide plasma levels.
  • Drugs that prolong PR interval (e.g., class I antiarrhythmics): increase risk of cardiac conduction delay.

Moderate Interactions (Monitor Closely)

  • Alcohol: enhances CNS depression and dizziness.
  • Hormonal contraceptives: may reduce contraceptive effectiveness.
  • Other antiepileptics (e.g., valproate, topiramate): may require dose adjustments.
  • Serotonergic agents: monitor for serotonin syndrome signs.
  • Antihypertensives: potential additive hypotensive effect.

Frequently Asked Questions

Lacosamide Strides is used as an adjunctive therapy for the treatment of partial‑onset seizures and focal epilepsy. It helps reduce the frequency of seizures in patients whose seizures are not fully controlled by other antiepileptic medications.

Lacosamide works by enhancing the slow inactivation of voltage‑gated sodium channels in neurons. This stabilizes neuronal membranes, limits repetitive firing, and reduces hyper‑excitability that leads to seizure activity.

The dosage of lacosamide is individualized by the prescribing clinician based on the patient’s clinical condition, response, and tolerability. The prescriber determines the appropriate starting dose and any subsequent titration.

The safety of lacosamide in pregnancy and lactation has not been definitively established. Healthcare providers should weigh the potential benefits against possible risks and discuss alternative options when appropriate.

To order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Lacosamide’s unique mechanism—enhancing slow sodium‑channel inactivation—differs from many traditional antiepileptics that target fast inactivation. This can provide complementary seizure control when combined with other agents, and it is generally well‑tolerated compared with some older drugs that have broader side‑effect profiles.

Lacosamide Strides should be stored at ambient temperature, below 25 °C, in its original packaging to protect from moisture and light. Keep the product out of reach of children and avoid storing in humid environments.

The medication is administered orally, typically as a tablet or oral formulation, and should be taken with or without food as directed by the prescriber. Swallow the tablet whole with water; do not crush or chew unless specifically instructed.

Serious risks include the potential for suicidal thoughts or behavior, severe skin reactions such as Stevens‑Johnson syndrome, cardiac conduction abnormalities like PR‑interval prolongation, and rare cases of respiratory depression, especially when combined with other central nervous system depressants.

Patients with known hypersensitivity to lacosamide or any component of the formulation should avoid it. Additionally, individuals with significant cardiac conduction disorders, uncontrolled severe hepatic or renal impairment, or those taking contraindicated medications should not use lacosamide without close medical supervision.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Lacosamide

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT